375 results on '"Piot, Christophe"'
Search Results
2. PPARβ/δ priming enhances the anti-apoptotic and therapeutic properties of mesenchymal stromal cells in myocardial ischemia–reperfusion injury
3. Correction: PPARβ/δ priming enhances the anti-apoptotic and therapeutic properties of mesenchymal stromal cells in myocardial ischemia–reperfusion injury
4. Fractional Flow Reserve to Guide Treatment of Patients With Multivessel Coronary Artery Disease
5. Routine CYP2C19 Genotyping to Adjust Thienopyridine Treatment After Primary PCI for STEMI: Results of the GIANT Study
6. In-Hospital and 1-Year Clinical Results from the French Registry Using Polymer-Free Sirolimus-Eluting Stents in Acute Coronary Syndrome and Stable Coronary Artery Disease
7. Hemodynamic Performances and Clinical Outcomes in Patients Undergoing Valve-in-Valve Versus Native Transcatheter Aortic Valve Implantation
8. Mesenchymal stromal cells for improvement of cardiac function following acute myocardial infarction: a matter of timing.
9. TCT-185 Safety and Performance Registry for an All-Comers Subject Population With the Limus-Eluting Orsiro Mission Stent System Within Daily Clinical Practice: 12-Month Results of the BIOFLOW-VIII Registry
10. Assessment of the area at risk after acute myocardial infarction using 123I-MIBG SPECT: Comparison with the angiographic APPROACH-score
11. Sustained quality of life improvement after intracoronary injection of autologous bone marrow cells in the setting of acute myocardial infarction: results from the BONAMI trial
12. Mesenchymal stromal cells for improvement of cardiac function following acute myocardial infarction: a matter of timing
13. Editorial: New strategies to inhibit cell death in myocardial ischemia-reperfusion injury: how to succeed? Volume II
14. Heart rate reduction after genetic ablation of L-type Cav1.3 channels induces cardioprotection against ischemia-reperfusion injury
15. Anti-apoptotic peptide for long term cardioprotection in a mouse model of myocardial ischemia–reperfusion injury
16. Unrestricted use of polymer-free sirolimus eluting stents in routine clinical practice
17. A prospective study comparing short versus standard dual antiplatelet therapy in patients with acute myocardial infarction: design and rationale of the TARGET-FIRST trial
18. Translating Cardioprotective Strategies into Clinical Settings
19. Predictors of ventricular remodelling in patients with reperfused acute myocardial infarction and left ventricular dysfunction candidates for bone marrow cell therapy: insights from the BONAMI trial
20. Editorial: New Strategies to Inhibit Cell Death in Myocardial Ischemia-Reperfusion Injury: How to Succeed?
21. Transcatheter aortic valve implantation in patients with uninterrupted vitamin K antagonists
22. PPARβ/δ preconditioning increased the cardioprotective effects of MSC in IR injury
23. A randomized trial of platelet reactivity monitoring-adjusted clopidogrel therapy versus prasugrel therapy to reduce high on-treatment platelet reactivity
24. Intracoronary administration of darbepoetin-alpha at onset of reperfusion in acute myocardial infarction: Results of the randomized Intra-Co-EpoMI trial
25. PPARβ/δ preconditioning increased the cardioprotective effects of human MSC in IR injury
26. Patent Foramen Ovale Closure or Anticoagulation vs. Antiplatelets after Stroke
27. Cardiac mGluR1 metabotropic receptors in cardioprotection
28. Delayed Postconditioning: Not Too Late?
29. Could heart rate play a role in pericardial inflammation?
30. Additional file 1 of PPARβ/δ priming enhances the anti-apoptotic and therapeutic properties of mesenchymal stromal cells in myocardial ischemia–reperfusion injury
31. PPARβ/δ Priming Enhances the Anti-Apoptotic and Therapeutic Properties of Mesenchymal Stromal Cells in Myocardial Ischemia-Reperfusion Injury
32. The RIPOST-MI study, assessing remote ischemic perconditioning alone or in combination with local ischemic postconditioning in ST-segment elevation myocardial infarction
33. Fractional Flow Reserve to Guide Treatment of Patients With Multivessel Coronary Artery Disease
34. PPARβ/δ Is Required for Mesenchymal Stem Cell Cardioprotective Effects Independently of Their Anti-inflammatory Properties in Myocardial Ischemia-Reperfusion Injury
35. Cyclosporine before PCI in Patients with Acute Myocardial Infarction
36. Postconditioning attenuates no-reflow in STEMI patients
37. What is the Role of Erythropoietin in Acute Myocardial Infarct? Bridging the Gap Between Experimental Models and Clinical Trials
38. Cardioprotection by clopidogrel in acute ST-elevated myocardial infarction patients: a retrospective analysis
39. Cardioprotection in the Clinical Setting
40. Effect of Cyclosporine on reperfusion injury in acute myocardial infarction
41. Postconditioning in man
42. Routine CYP2C19 genotyping to adjust antiplatelet therapy
43. Rationale and design of the Cyclosporine to ImpRove Clinical oUtcome in ST-elevation myocardial infarction patients (the CIRCUS trial)
44. Use of N-terminal prohormone brain natriuretic peptide assay for etiologic diagnosis of acute dyspnea in elderly patients
45. Myocardial Injury After Balloon Predilatation Versus Direct Transcatheter Aortic Valve Replacement: Insights From the DIRECTAVI Trial
46. Morphine mimics the antiapoptotic effect of preconditioning via an Ins(1,4,5)[P.sub.3] signaling pathway in rat ventricular myocytes
47. Clinical Outcomes in Patients Treated With Biodegradable-Polymer Biolimus-Eluting Stents and 6 Months of Dual-Antiplatelet Therapy: The French eBiomatrix 6-Month DAPT Registry.
48. Down-regulation of the transcription factor ZAC1 upon pre- and postconditioning protects against I/R injury in the mouse myocardium
49. Pharmacological approaches to reperfusion therapy
50. Intracoronary autologous mononucleated bone marrow cell infusion for acute myocardial infarction: results of the randomized multicenter BONAMI trial
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.